Milk transfer and neonatal safety of tacrolimus

Annals of Pharmacotherapy

Volumn 37, Issue 6, 2003, Pages 815-818

  French, Amy E ^a   Soldin, Steven J ^b   Soldin, Offie P ^c   Koren, Gideon ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c Soldin Research and Consultants Inc   (United States)

Author keywords

Breast feeding; Milk transfer; Tacrolimus

Indexed keywords

TACROLIMUS;

ADULT; ARTICLE; BREAST FEEDING; BREAST MILK; CASE REPORT; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG MILK LEVEL; DRUG SAFETY; FEMALE; HUMAN; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STEADY STATE; TANDEM MASS SPECTROMETRY;

ADULT; AREA UNDER CURVE; BREAST FEEDING; FEMALE; HUMANS; INFANT; MILK, HUMAN; PREGNANCY; TACROLIMUS;

EID: 0038823935     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C312     Document Type: Article

References (11)

1. Jusko WJ, Thomson AW, Fung J, McMaster P, Wong SH, Zylber-Katz E, et al. Consensus document: therapeutic monitoring of tacrolimus (FK-506). Ther Drug Monit 1995;17:606-14.
2. Jain A, Venkataramanan R, Fung JJ, Gartner JC, Lever J, Balan V, et al. Pregnancy after liver transplantation under tacrolimus. Transplantation 1997;64:559-65.
3. Volosov A, Napoli KL, Soldin SJ. Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography - tandem mass-spectrometry. Clin Biochem 2001;34:285-90.
4. Product monograph: Prograf (tacrolimus). Markham, ON: Fujisawa Canada, 2001.
5. Hytten FE. Clinical and chemical studies in human lactation. Br Med J 1954;1:175-82.
6. Lonnerdal B, Forsum E, Hambraeus L. A longitudinal study of the protein content of human milk from well-nourished Swedish mothers. Nutr Metab 1977;21(suppl 1):106-9.
7. Braun F, Lorf T, Schutz E, Christians U, Grupp C, Sattler B, et al. Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus. Transplant Proc 1996;28:3175-6.
8. Braun F, Schutz E, Christians U, Lorf T, Schiffmann JH, Armstrong VW. et al. Pitfalls in monitoring tacrolimus (FK 506). Ther Drug Monit 1997; 19:628-31.
9. Staatz CE, Taylor PJ, Tett SE. Comparison of an ELISA and an LC/MS/MS method for measuring tacrolimus concentrations and making dosage decisions in transplant recipients. Ther Drug Monit 2002;24:607-15.
10. Murthy JN, Davis DL, Yatscoff RW, Soldin SJ. Tacrolimus metabolite cross-reactivity in different tacrolimus assays. Clin Biochem 1998; 31: 613-7.
11. Ghoshal AK, Soldin SJ. IMx tacrolimus II assay: is it reliable at low blood concentrations? A comparison with tandem MS/MS. Clin Biochem 2002;35:389-92.